Atomwise, which uses AI to improve drug discovery, raises $45M Series A


Atomwise, which uses deep learning to shorten the process of discovering new drugs, has raised a $45 million Series A. The round was led by Monsanto Growth Ventures, Data Collective (DCVC) and B Capital Group. Baidu Ventures, Tencent and Dolby Family Ventures, which are all new investors in Atomwise, also participated, as well as returning investors Y Combinator, Khosla Ventures and DFJ.

Featured Image: Atomwise


from TechCrunch http://ift.tt/2tnrNT4
via IFTTT

Comments

Popular posts from this blog

Destiny 2's long-awaited "Go Fast" update goes live today

Easter Sale from TheGameCollection now live

Yucatan is the neo-Mexican space punk racer you've been waiting for